Synergistic activity of dispersin B and benzoyl peroxide against Cutibacterium acnes/Staphylococcus epidermidis dual-species biofilms
PLOS ONE · 27.03.2025 · 20 (3) · e0320662
DOI: 10.1371/journal.pone.0320662 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 27.03.2025. Verfasst von Jeffrey B Kaplan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, American University, Washington, District of Columbia, United States of America. Hauptthemen laut MEDLINE: Biofilms, Staphylococcus epidermidis, Benzoyl Peroxide, Glycoside Hydrolases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kane Biotech Inc..
Abstract (Originalsprache)
Cutibacterium acnes plays a key role in the development of acne vulgaris, with biofilm formation contributing to its persistence and resistance to antimicrobial treatments. A critical component of C. acnes biofilms is poly- N -acetylglucosamine (PNAG), an exopolysaccharide that facilitates both biofilm stability and biocide resistance. This study evaluated the efficacy of the PNAG-degrading enzyme dispersin B in enhancing the susceptibility of C. acnes biofilms to benzoyl peroxide (BP), a common anti-acne agent. Dual-species biofilms of C. acnes and Staphylococcus epidermidis , which has been shown to promote C. acnes biofilm growth under aerobic conditions, were cultivated in glass tubes and treated with dispersin B (5–80 µg/mL), BP (0.1–2.5%), or a combination of both. Dispersin B or BP alone reduced C. acnes colony-forming units (CFUs) by 1–2 log units. However, sequential treatment with dispersin B followed by BP achieved a synergistic effect, yielding a >6-log reduction in CFUs. Remarkably, concentrations as low as 5 µg/mL dispersin B combined with 0.5% BP efficiently eradicated C. acnes from the dual-species biofilms. These findings highlight the protective role of PNAG against BP and demonstrate the potential of dispersin B as an adjunctive therapy to enhance the efficacy of BP in acne treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biology, American University, Washington, District of Columbia, United States of America.
- Laboratory for Skin Research, Institute for Medical Research, Galilee Medical Center, Nahariya, Israel.
- Kane Biotech, Inc., Winnipeg, Manitoba, Canada.
- The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
ORCID-Profile: Jeffrey B Kaplan, Robert B Huizinga
Förderung
- Kane Biotech Inc.
Zitieren
APA
Kaplan, J. B., Muzaleva, A., Sailer, M., Huizinga, R. B., & Kridin, K. (2025). Synergistic activity of dispersin B and benzoyl peroxide against Cutibacterium acnes/Staphylococcus epidermidis dual-species biofilms. PLOS ONE, 20(3), e0320662. https://doi.org/10.1371/journal.pone.0320662
Vancouver
Kaplan JB, Muzaleva A, Sailer M, Huizinga RB, Kridin K. Synergistic activity of dispersin B and benzoyl peroxide against Cutibacterium acnes/Staphylococcus epidermidis dual-species biofilms. PLOS ONE. 2025;20(3):e0320662. doi:10.1371/journal.pone.0320662
BibTeX
@article{Kaplan2025,
author = {Kaplan, Jeffrey B and Muzaleva, Anna and Sailer, Miloslav and Huizinga, Robert B and Kridin, Khalaf},
title = {Synergistic activity of dispersin B and benzoyl peroxide against Cutibacterium acnes/Staphylococcus epidermidis dual-species biofilms},
journal = {PLOS ONE},
year = {2025},
volume = {20},
number = {3},
pages = {e0320662},
doi = {10.1371/journal.pone.0320662}
}
EUVIMED